The Federal Law No. 180-FZ dated 23 June 2016 'On Biomedical Cell Products' is aimed at developing the sector of biomedical technologies in Russia.
The Law has been developed with a view of the best international practices and regulates relations in connection with the development, pre-clinical trials, expertise, state registration, clinical trials, production, sale, storage, transportation, use, destruction, import in and export from the Russian Federation of biomedical cell products for the prevention, diagnosing and treatment of diseases (states), pregnancy maintenance and medical rehabilitation of a patient, as well as in connection with the donation of biological material for the production of biomedical cell products.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
